Introduction
============

Over the last 50 years, there has been relatively little progress related to the etiology and diagnosis of chronic bronchitis (CB) in adults. Bronchial mucus hypersecretion is the classically accepted cardinal feature, which usually manifests as a productive cough on most days during at least three consecutive months for 2 or more successive years.[@b1-copd-11-1911],[@b2-copd-11-1911] Nonobstructive or simple chronic bronchitis (NCB) contrasts with "chronic obstructive bronchitis", which is included within the definition of chronic obstructive pulmonary disease (COPD).[@b3-copd-11-1911] Clinicians and researchers have generally focused on obstructive CB because of its high mortality,[@b4-copd-11-1911] propensity for acute COPD exacerbations, and its association with excessive forced expiratory volume in 1 second decline in more advanced COPD.[@b5-copd-11-1911] Nonetheless, NCB is not a trivial condition, affecting an estimated nine million individuals in the US, predisposing them to recurrent chest infections, absenteeism from work, a poorer quality of life, and possibly increased mortality.[@b6-copd-11-1911] Thus, regardless of whether it is obstructive or not, adult CB has substantial public health implications.

Bronchial infection, air pollution, personal and secondhand tobacco smoke exposure, occupation, heredity, allergy, asthma, and socioeconomic status have been proposed to be etiological factors for CB.[@b2-copd-11-1911],[@b7-copd-11-1911] The assessment of the relative importance of these individual factors has been challenging,[@b7-copd-11-1911] such that personal smoking is widely regarded as the major risk factor, and there is often little recognition of other potential factors, including allergies.[@b2-copd-11-1911],[@b8-copd-11-1911],[@b9-copd-11-1911] Likewise, the precise role of childhood and current adult asthma remains the key areas of interest, particularly when associated with CB-related COPD.[@b10-copd-11-1911] Prospectively collected data from childhood to middle age is relatively scarce thereby limiting the investigation of these questions. Previous data relate to a much higher prevalence of smoking 50 years ago, especially for males, and there is a lack of more recent studies that have addressed the multifactorial nature of adult CB.

By using longitudinal data from the prospective follow-up of the Tasmanian Longitudinal Health Study (TAHS), we evaluated the association between independent host and environmental factors in childhood (at the age of 7 years) and middle age (in mid-forties) for having CB in mid-adult life. We further investigated by CB phenotypes, and hereafter refer to CB in middle age as simply "adult CB".

Materials and methods
=====================

Study design and population
---------------------------

Subjects were participants in the 5th decade follow-up of the TAHS, which is a population-based family study of 45,900 participants that commenced in 1968. The methods for the baseline and subsequent follow-up studies have been published.[@b11-copd-11-1911]--[@b17-copd-11-1911] Briefly, the "probands" who were born in 1961 and schooled in Tasmania in 1968 (n=8,583 \[99%\]) were studied by analyzing questionnaire responses and by performing spirometry when they were 7 years old. Respiratory questionnaires were also completed by parents (n=17,035) and siblings (n=21,035). Of the original 8,583 probands, to 7,312 (85%), who were retraced between 2002 and 2004, a detailed postal survey was then sent out when the probands were aged in their early-to-mid forties. A total of 5,729 (78%) responded, and this represented two-thirds (67%) of the original cohort. Respondents were chosen to participate in a clinical laboratory study based on either participation in multiple follow-up studies (including the 1974 clinical study and/or 1992 follow-up visits) or the presence of adult asthma and/or CB. Of the 2,373 invited, 1,389 (58.5%) participated. The main analysis here was based on the questionnaire data collected in 1968 and 2004 (n=5,729), with the subsequent analysis of post-bronchodilator (BD) spirometry and skin prick testing for those who participated in the clinical study between 2006 and 2008 (n=1,389).

Data collection methods
-----------------------

The predicted values for spirometry when participants were aged 7 years and in middle age were calculated using reference values from the Global Lung Initiative.[@b18-copd-11-1911] Parent-completed school medical records, which included history of childhood infections and immunizations, were accessed at the time of the 2004 postal survey.

Clinical definitions
--------------------

### Outcomes

Adult chronic bronchitis (adult CB) was defined by a series of affirmative responses to the 2004 postal survey questions "Do you usually have phlegm in your chest when you do not have a cold?"; "Are there months in which you have phlegm in your chest on most days?"; "Do you bring up this phlegm on most days for at least 3 months each year?"; and if yes, then "For how many years have you had this phlegm?" This was followed by three options: "less than 2 years; 2--5 years; more than 5 years", of which the latter two fulfilled the Lancet criteria.[@b1-copd-11-1911]

Obstructive CB was defined similar to that used for defining adult CB, but in the context of post-BD airflow obstruction in the 2006--2008 laboratory study, which was defined by the lower limit of normal predicted values and expressed as *z*-scores.[@b18-copd-11-1911],[@b19-copd-11-1911]

### Exposures

Asthma-ever, based on participant recall, was defined by an affirmative response to the 2004 postal survey question, "Have you, at any time in your life, suffered from attacks of asthma or wheezy breathing?" Current adult asthma was defined as a history of asthma and/or wheezy breathing, when without a cold, in the last 12 months.[@b20-copd-11-1911]

Allergy history in 1968 was defined by the affirmative response by parents and/or guardian to a history of food or medicine allergy, childhood eczema, and hives. Allergy history in 2004 was a history of allergy that was recalled by participants with regard to ever-eczema, hay fever, and/or allergy to food, medicine, dust, pollens, and/or animals.

Personal active smoking in 2004 was defined by the question "In your lifetime, have you smoked at least 100 cigarettes or equal amounts of cigars, pipes, or other tobacco product?", and was expressed by smoking status (never, past, and current), and smoking duration and intensity (pack-years, where 1 pack-year is equivalent to smoking 20 cigarettes per day for 1 year).

Current childhood asthma was defined by episodes of "asthma or wheezy breathing" within the preceding 12 months. A modified classification for childhood asthma (and/or wheezy breathing) severity was based on the Australian National Asthma Council document of 2006 and was determined by the number, frequency, and duration of childhood asthma and/or wheezy breathing episodes in 1968.[@b17-copd-11-1911] Specifically "episodic" asthma included either those with asthma episodes up to 3 months that lasted between a week to a month or fortnight to monthly episodes that lasted for a week.

Childhood bronchitis was defined by an affirmative parental response to the 1968 question, "Has he/she at any time in his/her life suffered from attacks of bronchitis or attacks of cough with sputum (phlegm) in the chest ('loose' or 'rattly' cough)?" Recurrent childhood bronchitis was defined by a threshold of two childhood episodes, with increasing severity categories predetermined by the survey question, "Since the attacks began, approximately how many has he/she had altogether?" Childhood chronic bronchitis was defined by the response, "never free of loose cough for more than a day or two".

See [Supplementary materials](https://www.dovepress.com/get_supplementary_file.php?f=103908.pdf) for other definitions, including skin prick testing.

Statistical analysis
--------------------

All analyses were carried out using the statistical software Stata (release 12; Stata Corporation, College Station, TX). Overall prevalence in the postal survey was based on the entire cohort, whereas sampling weights were used for the prevalence in the laboratory study. Logistic regression was used to examine the associations between the exposures and current bronchitis as a categorical variable. The multivariable models were adjusted for a priori confounders and additionally adjusted for confounders that changed the estimates of the associations by at least 10% ([Supplementary materials](https://www.dovepress.com/get_supplementary_file.php?f=103908.pdf)). Associations for variables not included in the models are summarized in [Table S1](https://www.dovepress.com/get_supplementary_file.php?f=103908.pdf). Independent associations were calculated using models containing exposure variables adjusted for one another. Biologically plausible interactions (or multiplicative effects) were investigated by including current asthma, smoking,[@b16-copd-11-1911] and sex, and results were stratified if a statistical interaction was present. Those with missing data were excluded from individual analyses, consistent with complete case analysis. A conventional cut-off of *P*\<0.05 was used to determine statistical significance. Corrections for multiple comparisons were not applied as there were more associations than one would expect by chance, and almost all analyses were based on findings previously reported in the literature.[@b7-copd-11-1911]

Ethics
------

This study was approved by the Human Ethics Review Committees at The Universities of Melbourne (approval number 040375), Tasmania (040375.1), New South Wales (08094), the Alfred Hospital (1118/04), and Royal Brisbane & Women's Hospital Health Service District (2006/037). Written informed consent was obtained from all participants.

Results
=======

Descriptive characteristics of participants
-------------------------------------------

The mean age of the participants at the 2004 postal survey was 43 (standard deviation 0.8) years ([Table 1](#t1-copd-11-1911){ref-type="table"}). The prevalence of self-reported CB in this survey (hereafter referred to simply as adult CB) was 6.1% (95% confidence interval \[CI\]: 5.5, 6.8). There was modest evidence that the prevalence was higher for males than females (6.7% \[5.8--7.7\] versus 5.5% \[4.7--6.4\], *P*=0.052).

The lung function data from the 2006--2008 laboratory study have been published (at the mean age of 45 years), where 10% (n=131) fulfilled the criterion for post-BD airflow obstruction.[@b16-copd-11-1911] Of those with adult CB, 19% (n=22/117) also had post-BD airflow obstruction of any severity, but only 4.3% (n=5/117) had at least moderately severe chronic airflow limitation.

Higher proportions of participants with adult CB had asthma and allergy in childhood and middle age than those without adult CB ([Table 1](#t1-copd-11-1911){ref-type="table"}). Of participants in the 1968 survey, 3,170 (39%) reported at least two episodes of childhood bronchitis and 1,357 (17%) reported a history of asthma and/or wheezy breathing when they were 7 years old. A history of childhood asthma was present in 1,130 (36%) of those reporting recurrent bronchitis. Half of those with childhood asthma had a history of allergy (n=689, 50%). The prevalence of these childhood factors were similar to participants lost to follow-up.

Independent associations between smoking, asthma, and adult CB
--------------------------------------------------------------

Of all ever smokers, a greater proportion of current smokers of at least 20 pack-years had adult CB (42% \[95% CI: 37--47\]) compared with 14% without adult CB (\[95% CI: 13--15\], *P*\<0.0001). Current smoking at least 20 pack-years, and a 40 pack-year history of smoking regardless of smoking status were both associated with at least a three-fold increase in the odds of adult CB in a multivariable model (*P*\<0.001 and *P*=0.005, respectively) ([Table 2](#t2-copd-11-1911){ref-type="table"}). No association was seen in past smokers, regardless of pack-year history, and there was a dose--response relationship with the univariable smoking trend (*P* for trend \<0.001).

For current asthma and/or wheezy breathing, the strength of association was significantly higher than the estimate for current smoking at least 20 pack-years (odds ratio \[OR\]: 6.19 \[95% CI: 4.55, 8.42\] versus 3.03 \[95% CI: 2.14, 4.30\]). However, no interaction was observed between the effects of current asthma and current smoking on adult CB (*P*=0.655).

Specific associations between allergy history and adult CB
----------------------------------------------------------

A history of any allergy by middle age was independently associated with adult CB (OR: 2.07 \[95% CI: 1.57, 2.73\], *P*\<0.001) ([Table 3](#t3-copd-11-1911){ref-type="table"}). Specific positive associations between individual allergy histories and adult CB included animal allergy (*P*=0.001), pollen allergy (*P*\<0.001), food allergy (*P*=0.003), ever-eczema (*P*\<0.001), and hay fever (*P*\<0.001) ([Table 3](#t3-copd-11-1911){ref-type="table"}). The strength of associations between allergy history and adult CB was significantly lower than the estimate for current asthma, either when analyzed as a combined variable or in separate regression models. This contrasts with a lack of association between adult atopic sensitization and adult CB (OR: 1.20 \[95% CI: 0.83, 1.72\], *P*=0.330, n=1,232), which remained nonsignificant after adjusting for asthma status.

Independent associations between early life factors and adult CB
----------------------------------------------------------------

We found childhood hives (urticaria) (*P*=0.037), any history of childhood allergy (*P*=0.018), "episodic" childhood asthma (*P*=0.002), current childhood asthma (*P*=0.001), and male sex (*P*=0.009) to be independently associated with adult CB ([Table 4](#t4-copd-11-1911){ref-type="table"}). Parental bronchitis when participants were aged 7 years old was also significant (*P*≤0.001), with the strength of association for two affected parents being statistically greater than the estimate for personal allergy history. Results for parental bronchitis were essentially unchanged when adjusted for parental smoking.

The univariable association between childhood bronchitis of more than ten episodes and adult CB (OR: 1.95 \[95% CI: 1.39, 2.75\], *P*\<0.001) was not apparent after adjustment for childhood asthma severity. Similarly, the univariable association between exposure to maternal smoking and adult CB (OR: 1.38 \[95% CI: 1.10, 1.74\], *P*=0.005) was not present after adjustment for parental history of bronchitis symptoms ([Table S1](https://www.dovepress.com/get_supplementary_file.php?f=103908.pdf)). There was no univariable association with paternal smoking, and no interaction between the effects of childhood asthma and bronchitis on adult CB (*P* for interaction =0.389).

Independent associations for NCB and obstructive CB
---------------------------------------------------

In the sample that subsequently underwent post-BD spirometry (n=1,389), the weighted prevalence of adult NCB was 5.2%, 5.6% for spirometrically defined COPD in the absence of adult CB and 0.8% for the combination, that is, adult obstructive CB. In a model that included only adult smoking, asthma, and allergy exposures ([Table 5](#t5-copd-11-1911){ref-type="table"}), current smoking, especially of at least 20 pack-years, was associated with all of these outcomes. Current asthma was associated with spirometrically defined COPD (*P*\<0.001), with or without a reported history of adult CB. This contrasts with the association between self-reported allergy and adult NCB, in the absence of chronic airflow limitation (n=127, *P*=0.003). The estimates for obstructive CB were overlapping and imprecise; however, the OR was at least 3.1 for current smokers of \<20 pack-years (*P*=0.009); at least 9.6 for current smokers with a history of ≥20 pack-years (*P*\<0.001), and at least 2.5 for those with current asthma (*P*\<0.001). This pattern remained following adjustment for childhood bronchitis (data not shown).

There was neither an asthma--smoking interaction on this obstructive CB phenotype related to few numbers (n=22) nor synergy between current smoking and allergy history with regard to NCB.

Discussion
==========

This is a prospective study of a Caucasian population who were born in 1961, for whom we have longitudinal data from 1968 with regard to CB from childhood through to mid-adult life. We confirmed the strength of association between current asthma and adult CB was at least as high as the estimate for current smokers with at least 20 pack-years history. Although the associations with self-reported allergy were lower, they were still statistically significant, and this contrasted with the lack of association for former smokers. We also found associations between personal smoking, current asthma, and chronic airflow limitation both in the presence and absence of adult CB. This contrasts with self-reported allergy, which was only associated with adult NCB. Although childhood bronchitis was not found to impact upon CB in adults, our data have shown childhood allergy, childhood episodic asthma, as well as parental bronchitis to be relevant clinical predictors. We found no evidence of an independent association between current atopy measured by skin prick testing and adult CB.

"Asthma" as a cause of adult CB is often overlooked in adult clinical practice, despite its inclusion in major clinical guidelines.[@b2-copd-11-1911] Its potential as a risk factor has been illustrated by the Tucson Epidemiologic Study of Airway Obstructive Diseases, in which "active" physician-diagnosed asthma was associated with a ten-fold increase in incident adult CB over a period of 20 years.[@b21-copd-11-1911] Although our findings are consistent with this relationship, we also confirmed a history of multiple allergies to be associated with CB in middle age. This link between allergy history and adult CB is similar to data from the National Population Health Survey of middle-aged Canadian adults (n=7,710).[@b22-copd-11-1911] The Tucson study also showed a lack of association with objective measures such as atopic sensitization or serum immunoglobulin E level measured at baseline,[@b21-copd-11-1911] and this is consistent with our findings. This reflects potential methodological differences between objective skin prick testing and subjective recall of an allergic history as adults. On the one hand, atopic sensitization may not be representative of clinical illness, and skin prick test positivity can wane with increasing age. On the other hand, subjective recall by adults can be frequently inaccurate with a tendency to reflect more severe cases, or possibly, postnasal drip from nonallergic rhinitis may be mislabeled as hay fever.

We found the strongest association between adult CB and current asthma, even when compared with current cigarette smokers with at least a 20-pack-year history. The significant but lesser associations for allergic history still suggest that a role for asthma and allergy has been underappreciated. Like smoking, we have found preliminary evidence to suggest current asthma to be associated with obstructive CB, in contrast to an allergic history that was associated with NCB. The allergic mechanism most likely relates to T-helper type 2 inflammation in the asthmatic airway, as interleukins-4 and -13 (or T-helper type 2 cytokines) from the allergic response have been linked to chronic mucus hypersecretion.[@b23-copd-11-1911] Similar to tobacco smoking,[@b10-copd-11-1911] these data raise the possibility that chronic mucus hypersecretion from symptomatic asthma might be a potential marker for early chronic airflow limitation in mid-adult life.

Early-life factors for COPD are increasingly being recognized,[@b24-copd-11-1911] but there has not been a similar emphasis or interest for adult CB. In this study, we have documented a relationship between childhood asthma and/or allergy and the occurrence of adult CB in mid-adult life, although null relationships were seen for some asthma severity categories that contained few numbers. It is important to note that our participants with asthma were born in 1961, which was a time before the widespread use of inhaled corticosteroid therapy, and so our estimates may be greater than those seen for children with asthma belonging to more recent generations. More data are needed to assess the relevance of the occurrence of early life asthma and allergy to individuals presenting in middle-to-older age with symptoms consistent with CB.

A positive association with adult CB was also seen for parental bronchial symptoms noted when participants were aged only 7 years old, and this contrasts the lack of association with recurrent cough at that time in the children themselves. This was an unexpected null finding, although there were relatively few with chronic childhood symptoms. Although hereditary causes of adult CB have been recognized for several decades,[@b7-copd-11-1911] there are few data that quantify the strength of an association. In one study of 44 probands with severe, early-onset, non-α-1-antitrypsin deficiency-related COPD, the proportion of first-degree relatives who reported smoking-related CB was significantly higher than age- and sex-matched control smoking subjects despite similar pack-year histories (30% versus 13%).[@b25-copd-11-1911] This genotype-by-smoking interaction supports a familial predisposition relating to adult CB.

Our finding of a lack of association with adult CB for past smokers is not widely documented,[@b2-copd-11-1911] but may be consistent with simple (or mucoid) bronchitis being the predominant form of adult CB in this subgroup. This form is reversible in most smokers, with a reduction in expectoration occurring when an individual quits smoking.[@b9-copd-11-1911] The null finding for an asthma--smoking interaction with regard to obstructive CB most likely relates to insufficient power from few case numbers.

The major strength of our study was the prospectively collected data from a large population-based sample, where two-thirds of the original cohort (n=8,583) responded 37 years later to the 2004 postal survey (n=5,729). Our results with a relatively low attrition rate may be more representative of the general population than most other studies. In terms of our definition for adult CB, we adopted a series of questions using the term "bring up phlegm" in line with the original description,[@b1-copd-11-1911] and this structure provides greater consistency than responses to a single question. We acknowledge that our questions and others used by other major epidemiological studies[@b26-copd-11-1911],[@b27-copd-11-1911] might not identify those who have a tendency to swallow their mucus and so not report expectoration,[@b5-copd-11-1911] which effectively biases our estimates toward the null.

This study also had limitations. First, the analytical design of the 2004 postal survey to all eligible participants did not include spirometric data, except for a subsequent subset. Therefore, we were unable to provide regression estimates for those with and without CB-associated COPD for the entire group. Similarly, as this was a whole-of-population study, it was not feasible to perform high-resolution computed tomography and identify the expected small number of participants with bronchiectasis. Nor was there exposure data from 2004 to examine for the potential confounding effect of ambient air pollution. Second, the assessment of CB was limited to questionnaire data from childhood to middle age, with different definitions used at these time points, so the natural history of CB could not be examined. Third, a history of allergy would be subject to recall bias, such that milder cases may not be recalled. Adults with respiratory symptoms such as CB may have the tendency to recollect more information, which might have a variable influence on the estimates. Fourth, the estimates for the CB--COPD overlap analysis are imprecise due to relatively fewer participants in the questionnaire phase having post-BD spirometry. Fifth, as our participants were almost exclusively Caucasian in ethnicity and in their mid-forties, this might limit the generalizability of our findings to other populations.

Conclusion
==========

The independent associations between current asthma, self-reported allergy, and adult CB, regardless of post-BD airflow obstruction, suggest a greater contribution from asthma and allergy than previously thought. The identification of childhood allergic history, childhood asthma, and parental bronchitis symptoms, as clinical predictors of adult CB, raises the possibility of some of this burden having origins in childhood. Our findings that examined spirometrically defined COPD and adult CB separately and in combination also raise the possibility for different roles of asthma and allergy. CB in adults, even if not associated with airway obstruction, is linked to considerable morbidity and possible mortality. A better understanding of NCB and obstructive CB will optimize the approach for its prevention, diagnosis, and treatment.[@b6-copd-11-1911]

MeSH terms
==========

1.  Epidemiology \[H02.403.720.500\]

2.  Bronchitis, Chronic \[C08.127.446.567\]

3.  Bronchitis, Chronic \[C08.381.495.146.567\]

4.  Bronchitis, Chronic \[C08.381.495.389.500\]

5.  Bronchitis, Chronic \[C08.730.099.567\]
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###### 

Main characteristics of all TAHS participants (and nonresponders) to the 2004 postal survey, stratified by adult chronic bronchitis

  Clinical characteristics         Self-reported adult CB   Nonresponders (n=2,720)[a](#tfn2-copd-11-1911){ref-type="table-fn"}             
  -------------------------------- ------------------------ --------------------------------------------------------------------- --------- ------------
  Demographics                                                                                                                              
   Age in years, mean (SD)         42.8 (0.9)               42.9 (0.9)                                                            0.771     --
   Sex (male)                      2,673 (51)               193 (57)                                                              0.052     1,379 (51)
  Cigarette smoking                                                                                                                         
   Nonsmokers                      2,140 (42)               79 (24)                                                               \<0.001   --
   Ex-smoker \<20 pack-years       1,173 (23)               46 (14)                                                               \<0.001   --
   Ex-smoker \>20 pack-years       353 (7)                  13 (4)                                                                0.034     --
   Current \<20 pack-years         701 (14)                 51 (15)                                                               0.421     --
   Current \>20 pack-years         708 (14)                 143 (43)                                                              \<0.001   --
  Asthma and/or wheezy breathing                                                                                                            
   Asthma 1968                     889 (17)                 92 (27)                                                               \<0.001   405 (15)
   Asthma 2004                                                                                                                              
    None                           3,051 (58)               72 (21)                                                               \<0.001   --
    Remitted                       1,154 (22)               42 (12)                                                               \<0.001   --
    Current                        1,017 (19)               227 (66)                                                              \<0.001   --
  Allergic history                                                                                                                          
   Any allergy 1968                1,732 (34)               139 (42)                                                              0.002     856 (33)
   Any allergy 2004                2,475 (47)               224 (66)                                                              \<0.001   --
  Childhood bronchitis                                                                                                                      
   At least two episodes           2,043 (40)               147 (45)                                                              0.071     958 (36)
   At least ten episodes           434 (8)                  47 (14)                                                               0.015     218 (8)

**Notes:** Those with missing data were excluded from individual totals.

Consists of those not traced or those traced but not responding to the 2004 postal survey. Mean comparison test (age only) and cohort study summary statistics using Stata 12 SE was used to obtain the *P*-values.

**Abbreviations:** TAHS, Tasmanian Longitudinal Health Study; CB, chronic bronchitis; SD, standard deviation.

###### 

Independent associations between clinical characteristics and CB in middle age

  Clinical characteristics                             Self-reported adult CB (N=4,949 \[%\])                        
  ---------------------------------------------------- ---------------------------------------- ---------- --------- --------------------------------------------------------------------
  Male sex                                             2,377 (51)                               168 (58)   --        1.46 (1.12, 1.90)[\*](#tfn6-copd-11-1911){ref-type="table-fn"}
  Combined smoking history                                                                                 \<0.001   
   None                                                1,986 (43)                               78 (27)              1
   Ex-smoker \<20 pack-years                           1,094 (23)                               43 (15)              0.99 (0.67, 1.46)
   Ex-smoker \>20 pack-years                           331 (7)                                  12 (4)               0.86 (0.44, 1.59)
   Current \<20 pack-years                             625 (13)                                 42 (14)              1.54 (1.03, 2.32)[\*](#tfn6-copd-11-1911){ref-type="table-fn"}
   Current \>20 pack-years                             622 (13)                                 116 (40)             3.03 (2.14, 4.30)[\*\*](#tfn7-copd-11-1911){ref-type="table-fn"}
  Smoking status                                                                                           \<0.001   
   Never                                               1,986 (43)                               77 (26)              1
   Past                                                1,425 (31)                               56 (19)              0.62 (0.30, 1.30)
   Current                                             1,246 (27)                               158 (54)             1.36 (0.64, 2.88)
  Pack-year history                                                                                        \<0.001   
   None                                                2,283 (49)                               85 (29)              1
   Up to 10 pack-years                                 828 (18)                                 42 (14)              1.47 (0.69, 3.11)
   Between 10 and 20 pack-years                        638 (14)                                 38 (13)              1.38 (0.64, 2.98)
   Between 20 and 40 pack-years                        747 (16)                                 85 (29)              1.90 (0.90, 4.00)
   \>40 pack-years                                     162 (3)                                  40 (14)              3.19 (1.42, 7.17)[\*\*\*](#tfn8-copd-11-1911){ref-type="table-fn"}
  Asthma/wheezy breathing                                                                                  \<0.001   
   Never                                               2,723 (58)                               65 (22)              1
   Remitted                                            1,035 (22)                               38 (13)              1.29 (0.85, 1.96)
   Current (last 12 months)                            900 (19)                                 188 (65)             6.19 (4.55, 8.42)[\*\*](#tfn7-copd-11-1911){ref-type="table-fn"}
  Allergy history                                                                                          --        
   Any history                                         2,218 (48)                               195 (67)             2.07 (1.57, 2.73)[\*\*](#tfn7-copd-11-1911){ref-type="table-fn"}
  Passive smoking                                                                                          \<0.001   
   None                                                3,490 (75)                               166 (57)             1
   Between 1 and 3 hours/day                           735 (16)                                 58 (20)              1.05 (0.75, 1.47)
   At least 4 hours/day                                433 (9)                                  67 (23)              1.31 (0.92, 1.87)
  Parental bronchitis at least every 3 years in 1968                                                       --        
   Neither parent                                      4,071 (87)                               232 (80)             1
   Either or both                                      587 (13)                                 59 (20)              1.13 (0.82, 1.57)

**Notes:** Those with missing data were excluded from individual analyses.

All exposure variables are adjusted for one another in addition to participant education and occupation (estimates included in [Table S1](https://www.dovepress.com/get_supplementary_file.php?f=103908.pdf)). The combined smoking variable was initially used, then substituted for separate smoking status and pack-year variables;

*P*\<0.05;

*P*\<0.001;

*P*\<0.01.

**Abbreviations:** CB, chronic bronchitis; CI, confidence interval; OR, odds ratio.

###### 

Multivariable associations between allergy history and CB in middle age

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
  Allergy history in 2004   Self-reported adult CB (N=4,949 \[%\])              
  ------------------------- ---------------------------------------- ---------- -----------------------------------------------------------------------------
  Any history               2,218 (48)                               195 (67)   2.07 (1.57, 2.73)[\*](#tfn12-copd-11-1911){ref-type="table-fn"}

  Food allergy              542 (10)                                 62 (18)    1.80 (1.22, 2.63)[\*\*](#tfn13-copd-11-1911){ref-type="table-fn"}

  Medicine allergy          825 (16)                                 67 (20)    1.19 (0.83, 1.70)

  Dust allergy              787 (15)                                 104 (31)   Males: 2.04 (1.23, 3.38)[\*\*\*](#tfn14-copd-11-1911){ref-type="table-fn"}\
                                                                                Females: 2.62 (1.67, 4.12)[\*](#tfn12-copd-11-1911){ref-type="table-fn"}\
                                                                                *P* \[interaction\] =0.017

  Animal allergy            536 (10)                                 66 (19)    1.85 (1.26, 2.69)[\*\*\*](#tfn14-copd-11-1911){ref-type="table-fn"}

  Pollen allergy            1,525 (29)                               158 (46)   1.81 (1.35, 2.43)[\*](#tfn12-copd-11-1911){ref-type="table-fn"}

  Ever eczema               1,859 (36)                               173 (51)   1.67 (1.26, 2.22)[\*](#tfn12-copd-11-1911){ref-type="table-fn"}

  Hay fever                 2,547 (49)                               233 (69)   1.76 (1.30, 2.40)[\*](#tfn12-copd-11-1911){ref-type="table-fn"}
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:** Those with missing data were excluded from individual analyses.

Adjusted for male sex, current wheezing 2004, smoking (status and pack-years), parental bronchitis 1968, highest attained educational level, and participant occupation 2004;

*P*\<0.001;

*P*\<0.05;

*P*\<0.01.

**Abbreviations:** CB, chronic bronchitis; CI, confidence interval; OR, odds ratio.

###### 

Independent associations between early-life factors and CB in middle age

  Clinical characteristics when participants were aged 7 years   Self-reported adult CB (N=5,170 \[%\])                        
  -------------------------------------------------------------- ---------------------------------------- ---------- --------- ---------------------------------------------------------------------
  Male sex                                                       2,485 (51)                               179 (58)   --        1.39 (1.09, 1.77)[\*](#tfn18-copd-11-1911){ref-type="table-fn"}
  Childhood bronchitis                                                                                                         
   None                                                          2,492 (52)                               133 (45)   0.001     1
   1 episode only                                                384 (8)                                  30 (10)              1.38 (0.91, 2.08)
   2--5 episodes                                                 990 (21)                                 54 (18)              0.85 (0.60, 1.19)
   5--10 episodes                                                519 (11)                                 36 (12)              0.94 (0.62, 1.42)
   11--20 episodes                                               235 (5)                                  23 (8)               1.20 (0.72, 2.00)
   \>20 episodes                                                 165 (3)                                  20 (7)               1.33 (0.75, 2.35)
   Chronic symptoms                                              31 (1)                                   3 (1)                1.36 (0.45, 4.07)
  Asthma status                                                                                                                
   No asthma                                                     4,046 (83)                               227 (74)   \<0.001   1
   Remitted asthma                                               225 (5)                                  18 (6)               1.17 (0.71, 1.92)
   Current asthma                                                495 (10)                                 59 (20)              1.84 (1.26, 2.68)[\*](#tfn18-copd-11-1911){ref-type="table-fn"}
  Asthma severity                                                                                                              
   No asthma                                                     4,046 (83)                               227 (74)   \<0.001   1
   "Infrequent intermittent"                                     406 (8)                                  36 (12)              1.39 (0.92, 2.10)
    \\"Frequent intermittent"                                    25 (1)                                   2 (1)                0.49 (0.64, 3.78)
   "Episodic"                                                    139 (3)                                  22 (7)               2.32 (1.38, 3.92)[\*](#tfn18-copd-11-1911){ref-type="table-fn"}
   "Moderate-to-severe persistent"                               21 (0.4)                                 3 (1)                1.81 (0.51, 6.45)
  Allergy history                                                                                                    --        
   Any allergy                                                   1,627 (33)                               133 (43)             1.35 (1.05, 1.73)[\*\*](#tfn19-copd-11-1911){ref-type="table-fn"}
   Hives, at least once                                          963 (20)                                 84 (27)              1.34 (1.02, 1.76)[\*\*](#tfn19-copd-11-1911){ref-type="table-fn"}
  Bronchial symptoms reported by parent                                                                              \<0.001   
   Neither parent                                                3,841 (79)                               206 (67)             1
   One or either parent                                          871 (18)                                 79 (26)              1.61 (1.22, 2.13)[\*](#tfn18-copd-11-1911){ref-type="table-fn"}
   Both parents                                                  150 (3)                                  23 (7)               2.51 (1.56, 4.06)[\*\*\*](#tfn20-copd-11-1911){ref-type="table-fn"}

**Notes:** Those with missing data were excluded from individual analyses.

All exposure variables are adjusted for one another in addition to paternal occupation (estimates included in [Table S1](https://www.dovepress.com/get_supplementary_file.php?f=103908.pdf)). The "any allergy" variable was initially used, then hives only was substituted. Similarly, asthma status and asthma severity as well as bronchitis frequency and chronicity were substituted with other variables retained;

*P*\<0.01;

*P*\<0.05;

*P*\<0.001.

**Abbreviations:** CB, chronic bronchitis; CI, confidence interval; OR, odds ratio.

###### 

Relative associations between adult smoking, asthma, and allergy on airflow obstruction, CB, and its overlap

  Clinical characteristics in middle age                                  The CB--COPD overlap (N=1,307, adjusted OR \[95% CI\][a](#tfn23-copd-11-1911){ref-type="table-fn"})                                                                         
  ----------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------------------------
  Personal smoking[\*](#tfn24-copd-11-1911){ref-type="table-fn"}                                                                                                                                                                                      
   None                                                                   1                                                                                                     1                                                                     1
   Past \<20 pack-years                                                   0.96 (0.49, 1.86)                                                                                     1.27 (0.76, 2.12)                                                     2.08 (0.13, 33.6)
   Past \>20 pack-years                                                   2.11 (0.86, 5.14)                                                                                     0.83 (0.28, 2.40)                                                     9.67 (0.59, 160)
   Current \<20 pack-years                                                1.97 (0.98, 3.95)                                                                                     1.30 (0.67, 2.51)                                                     19.5 (2.13, 179)[\*\*](#tfn25-copd-11-1911){ref-type="table-fn"}
   Current \>20 pack-years                                                4.89 (2.73, 8.76)[\*\*\*](#tfn26-copd-11-1911){ref-type="table-fn"}                                   4.31 (2.58, 7.18)[\*\*\*](#tfn26-copd-11-1911){ref-type="table-fn"}   76.3 (9.56, 609)[\*\*\*](#tfn26-copd-11-1911){ref-type="table-fn"}
  Asthma/wheezy breathing[\*](#tfn24-copd-11-1911){ref-type="table-fn"}                                                                                                                                                                               
   Never                                                                  1                                                                                                     1                                                                     1
   Remitted                                                               1.05 (0.56, 1.98)                                                                                     0.71 (0.44, 1.14)                                                     3.64 (0.42, 31.3)
   Current                                                                4.93 (2.68, 9.07)[\*\*\*](#tfn26-copd-11-1911){ref-type="table-fn"}                                   1.55 (0.93, 2.58)                                                     20.6 (2.53, 167)[\*\*](#tfn25-copd-11-1911){ref-type="table-fn"}
  Allergy history                                                         1.12 (0.68, 1.84)                                                                                     1.94 (1.24, 3.03)[\*\*](#tfn25-copd-11-1911){ref-type="table-fn"}     2.00 (0.66, 6.08)

**Notes:** Those with missing data were excluded from individual analyses.

All exposure variables are adjusted for one another;

Univariable *P* for trend across ordered groups \<0.001;

*P*\<0.01;

*P*\<0.001.

**Abbreviations:** CB, chronic bronchitis; CI, confidence interval; COPD, chronic obstructive pulmonary disease; OR, odds ratio.
